{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:48:20Z","timestamp":1793414900001,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fund of Chengdu Medical College","award":["Grant CYJD22-01"],"award-info":[{"award-number":["Grant CYJD22-01"]}]},{"name":"Fund of Chengdu Medical College","award":["Grant CYSZD23-05"],"award-info":[{"award-number":["Grant CYSZD23-05"]}]},{"name":"Fund of Chengdu Medical College","award":["Grant CYJD22-01"],"award-info":[{"award-number":["Grant CYJD22-01"]}]},{"name":"Fund of Chengdu Medical College","award":["Grant CYSZD23-05"],"award-info":[{"award-number":["Grant CYSZD23-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Congenital dysfibrinogenemia is a rare autosomal dominant disorder involving abnormal fibrinogen function, leading to variable risks of bleeding and thrombosis. Its management during pregnancy is particularly challenging due to the potential for complications such as miscarriage, stillbirth, placental abruption, and fetal growth restriction. The absence of reliable predictive laboratory markers further complicate individualized risk assessment and clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 23-year-old primigravida was diagnosed with congenital dysfibrinogenemia after low fibrinogen levels were detected early in her pregnancy. Family history revealed similar fibrinogen abnormalities in her father and brother. Amniocentesis for fetal genetic testing was performed after a multidisciplinary team review that evaluated the bleeding risks, with no complications during or immediately following the procedure. Genetic testing confirmed congenital dysfibrinogenemia in both the mother and fetus. Throughout the pregnancy, the patient was closely monitored, with no signs of bleeding, thrombosis, or other complications. At 39.3 weeks, following a failed attempt at vaginal delivery, she underwent a cesarean section after fibrinogen replacement therapy. The surgery was uneventful, and there were no significant bleeding or thrombotic events postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case emphasizes the critical role of a multidisciplinary team approach in managing congenital dysfibrinogenemia during pregnancy, amniocentesis, and perinatal care. It demonstrates the effectiveness of thorough disease assessment and fibrinogen replacement therapy in preventing bleeding, thereby ensuring good outcomes for both the mother and fetus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-07834-3","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:40:09Z","timestamp":1751524809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multidisciplinary team management of congenital dysfibrinogenemia in pregnancy: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Meng Jie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"6","key":"7834_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","volume":"14","author":"SS Acharya","year":"2008","unstructured":"Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia. 2008;14(6):1151\u20138.","journal-title":"Haemophilia"},{"issue":"4","key":"7834_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0029-1225758","volume":"35","author":"P de Moerloose","year":"2009","unstructured":"de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009;35(4):356\u201366.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"7834_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jth.12916","volume":"13","author":"A Casini","year":"2015","unstructured":"Casini A, Neerman-Arbez M, Ariens RA, et al. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost. 2015;13(6):909\u201319.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"7834_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3760\/cma.j.issn.0253-2727.2021.07.005","volume":"42","author":"LY Huang","year":"2021","unstructured":"Huang LY, Zhang DL, Fu RF, et al. Analysis of gene mutation spectrum and pharmacokinetics of fibrinogen infusion in 146 cases of congenital fibrinogen disorders. Zhonghua Xue Ye Xue Za Zhi. 2021;42(7):555\u201362. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.07.005.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"5","key":"7834_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"7834_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119680","volume":"561","author":"J Yan","year":"2024","unstructured":"Yan J, Liao L, Deng D, Zhou W, et al. Guideline for diagnosis and management of congenital dysfibrinogenemia. Clin Chim Acta. 2024;561: 119680.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"7834_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22322","volume":"32","author":"L Xiang","year":"2018","unstructured":"Xiang L, Luo M, Yan J, et al. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: screening for congenital dysfibrinogenemia. J Clin Lab Anal. 2018;32(4): e22322.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"7834_CR8","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/jth.14216","volume":"16","author":"A Casini","year":"2018","unstructured":"Casini A, Undas A, Palla R, et al. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1887\u201390.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"7834_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","volume":"55","author":"J Zhou","year":"2015","unstructured":"Zhou J, Ding Q, Chen Y, et al. Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia. Blood Cells Mol Dis. 2015;55(4):308\u201315.","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"7834_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bjh.12085","volume":"160","author":"SE Shapiro","year":"2013","unstructured":"Shapiro SE, Phillips E, Manning RA, et al. Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia. Br J Haematol. 2013;160(2):220\u20137.","journal-title":"Br J Haematol"},{"issue":"3","key":"7834_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","volume":"125","author":"A Casini","year":"2015","unstructured":"Casini A, Blondon M, Lebreton A, et al. Natural history of patients with congenital dysfibrinogenemia. Blood. 2015;125(3):553\u201361.","journal-title":"Blood"},{"issue":"21","key":"7834_CR12","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1182\/blood.2020010116","volume":"138","author":"A Casini","year":"2021","unstructured":"Casini A, de Moerloose P. How i treat dysfibrinogenemia. Blood. 2021;138(21):2021\u201330.","journal-title":"Blood"},{"issue":"6","key":"7834_CR13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1046\/j.1538-7836.2003.00244.x","volume":"1","author":"MM Hanss","year":"2003","unstructured":"Hanss MM, Ffrench PO, Mornex JF, et al. Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost. 2003;1(6):1251\u20137.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"7834_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0038-1653741","volume":"73","author":"M Haverkate","year":"1995","unstructured":"Haverkate M, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost. 1995;73(1):151\u201361.","journal-title":"Thromb Haemost"},{"issue":"4","key":"7834_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","volume":"10","author":"F Peyvandi","year":"2012","unstructured":"Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European network of rare bleeding disorders. J Thromb Haemost. 2012;10(4):615\u201321.","journal-title":"J Thromb Haemost"},{"key":"7834_CR16","unstructured":"Jindal A, Sharma M, Karena ZV et al. Amniocentesis. 2023. In: StatPearls. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559247\/. Treasure Island (FL): StatPearls Publishing; Accessed 28 Feb 2025."},{"issue":"1","key":"7834_CR17","first-page":"e1","volume":"129","author":"K Navaratnam","year":"2022","unstructured":"Navaratnam K, Alfirevic Z. Royal college of obstetricians and gynaecologists. Amniocentesis and chorionic villus sampling. Green-top Guideline 8 BJOG. 2022;129(1):e1\u201315.","journal-title":"Green-top Guideline 8 BJOG"},{"issue":"3","key":"7834_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1182\/blood.V96.3.1191","volume":"96","author":"T Tarumi","year":"2000","unstructured":"Tarumi T, Martincic D, Thomas A, et al. Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome. Blood. 2000;96(3):1191\u20133.","journal-title":"Blood"},{"issue":"5","key":"7834_CR19","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jtha.2024.01.008","volume":"22","author":"A Casini","year":"2024","unstructured":"Casini A, Abdul Kadir R, Abdelwahab M, et al. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC subcommittee on factor XIII and fibrinogen. J Thromb Haemost. 2024;22(5):1516\u201321.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"7834_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/hae.13825","volume":"25","author":"V Valiton","year":"2019","unstructured":"Valiton V, Hugon-Rodin J, Fontana P, et al. Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review. Haemophilia. 2019;25(5):747\u201354.","journal-title":"Haemophilia"},{"key":"7834_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.thromres.2020.08.028","volume":"196","author":"W Peterson","year":"2020","unstructured":"Peterson W, Liederman Z, Baker J, et al. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thromb Res. 2020;196:127\u20139.","journal-title":"Thromb Res"},{"issue":"2","key":"7834_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jth.13923","volume":"16","author":"C Ross","year":"2018","unstructured":"Ross C, Rangarajan S, Karimi M, et al. Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency. J Thromb Haemost. 2018;16(2):253\u201361.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"7834_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.12669\/pjms.334.12828","volume":"33","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhu P, Zhang X. A Chinese family with congenital dysfibrinogenemia carries a heterozygous missense mutation in FGA: concerning the genetic abnormality and clinical treatment. Pak J Med Sci. 2017;33(4):968\u201372.","journal-title":"Pak J Med Sci"},{"issue":"46","key":"7834_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031644","volume":"101","author":"D Meng","year":"2022","unstructured":"Meng D, Zhang R, Ji C, et al. A low-dose therapy of fibrinogen supplement during perioperative period of total knee arthroplasty in an asymptomatic man with congenital dysfibrinogenemia: a case report. Medicine (Baltimore). 2022;101(46): e31644.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"7834_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.13058","volume":"167","author":"AD Mumford","year":"2014","unstructured":"Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a united Kingdom haemophilia centre doctors\u2019 organization guideline on behalf of the British committee for standards in haematology. Br J Haematol. 2014;167(3):304\u201326.","journal-title":"Br J Haematol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07834-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:18:09Z","timestamp":1781608689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-025-07834-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7834"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07834-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6137704\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and received formal approval from the Institutional Review Board of the Sichuan Provincial Women\u2019s and Children\u2019s Hospital, Grant No. 20250326-73. Written informed consent was obtained from the participant for publication of anonymized clinical data and research findings, including any accompanying images or case details. All procedures maintained strict confidentiality in accordance with institutional data protection protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and received formal approval from the Institutional Review Board of the Sichuan Provincial Women\u2019s and Children\u2019s Hospital. Written informed consent was obtained from the participant for publication of anonymized clinical data and research findings, including any accompanying images or case details. Written informed consent has been obtained from the patient to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"715"}}